Zimbabwe Expands Access to Twice-Yearly HIV Prevention Injection

Health authorities are set to receive a new consignment of Lenacapavir in July, expanding access to the twice-yearly HIV prevention injection. This rollout represents a significant advancement in the country's public health strategy, offering a more effective and manageable tool for infection prevention. Officials expect the initiative to reach a broader demographic, reducing the burden on existing healthcare infrastructure. Despite the logistical challenges of distribution, the government remains committed to integrating this breakthrough treatment into the national HIV response program. [iHarare News]